Cytosorbents
CTSO
#11207
Rank
โ‚ฌ0.97 M
Marketcap
0,31ย โ‚ฌ
Share price
0.03%
Change (1 day)
-61.25%
Change (1 year)

EPS for Cytosorbents (CTSO)

EPS in 2026 (TTM): -4,99ย โ‚ฌ

According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -5,15ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,31ย โ‚ฌ an increase over its 2024 EPS that were of -6,57ย โ‚ฌ.

EPS history for Cytosorbents from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,99ย โ‚ฌ116.2%
2025-2,31ย โ‚ฌ-64.85%
2024-6,57ย โ‚ฌ
2021-10,08ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Boston Scientific
BSX
2,20ย โ‚ฌ-142.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
2,16ย โ‚ฌ-141.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
0,86ย โ‚ฌ-116.72%๐Ÿ‡บ๐Ÿ‡ธ USA